Login

Username or email address

Enter your username or email address.

Password

Enter the password that accompanies your username.

Request new password

Progress in Mind Middle East and Africa

Topics
Congress highlights
- ECNP 2022
- ASUIP 2022
- EAN 2022
- COVID-19 MEA
- ECNP 2021
- EAN 2021
- APA 2019
Expert Views
Podcast
About Us

Search

The information on this site is exclusively intented for health care professionals.

ACCEPT DECLINE

Articles

Biological markers

Migraine 23 Feb, 2024 Read Time: 4 mins

Satellite symposium

Unveiling the Migraine Mystery: Exposing the Depths of Migraine Suffering

Burden of Migraine: Identifying Unmet Needs At the recent 4th Dubai Neurology Congress, UAE (23...
Schizophrenia 15 Oct, 2023 Read Time: 4 mins

Satellite symposium

Tracing the Arc of Progress: A Historical Exploration of Evolving Schizophrenia Treatments and Treatment Goals

What series of small steps can promote and maintain functional recovery in patients with...
Depression 15 Oct, 2023 Read Time: 4 mins

Satellite symposium

Navigating the Emotional Labyrinth in MDD

Initiating and optimizing treatment for patients with Major Depressive Disorder During The 27th...
Mental-Health 30 Oct, 2022 Read Time: 3 mins

Congress highlights Article

New Perspectives on Research and Clinical Care for ADHD

During the 3rd South Africa Multidisciplinary Congress for ADHD, Prof Stephen Faraone presented...
Depression 28 Oct, 2022 Read Time: 3 mins

Congress highlights

Redefining Treatment Expectations in Major Depressive Disorder (MDD)

Depression still leads the way in terms of the global burden of disease. In a seminar, sponsored by...
Depression 20 Oct, 2022 Read Time: 7 mins

Satellite symposium Article

Optimising outcomes in major depressive disorder

At the 35th ECNP Congress in Vienna, Austria (15−18th Oct), in a symposium titled ‘Optimising...
Depression, Schizophrenia 19 Oct, 2022 Read Time: 3 mins

Congress highlights Article

Highlights from ECNP 2022 – Day 3 – October 17th

Welcome to Progress in Mind’s live coverage of ECNP 2022. The 35th Congress of the European College...
Mental Health 18 Oct, 2022 Read Time: 3 mins

Congress highlights Article

Highlights from ECNP 2022 – Day 2 – October 16th

Welcome to Progress in Mind’s live coverage of ECNP 2022. The 35th Congress of the European College...
Depression 15 Sep, 2022 Read Time: 3 mins

Satellite symposium Congress highlights

Exploring dose–response relationships of antidepressant treatments: Efficacy and tolerability considerations

Nausea, constipation, diarrhea, dry mouth, headache, dizziness, nervousness, agitation, insomnia,...
Depression 15 Sep, 2022 Read Time: 5 mins

Satellite symposium Congress highlights

Anhedonia, emotional blunting and low motivation in MDD: What are the implications for functional recovery?

Besides sadness and anxiety, the emotional symptoms of depression also include the devastating...
Schizophrenia 11 Jul, 2022 Read Time: 1 min

Expert Views

World Mental Health Day helps show how mental health is physical health and should be approached as such

Mental health is a priority that strongly belongs to medicine as it is part of physical health,...
Mental Health 28 Jun, 2022 Read Time: 3 mins

Congress highlights Article

Highlights from EAN 2022 — Day 4 — June 28th

Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of...
Mental Health 27 Jun, 2022 Read Time: 3 mins

Congress highlights Article

Highlights from EAN 2022 — Day 3 — June 27th

Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of...
Mental Health 26 Jun, 2022 Read Time: 3 mins

Congress highlights Article

Highlights from EAN 2022 — Day 2 — June 26th

Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of...
Migraine, Parkinson's Disease 26 Jun, 2022 Read Time: 3 mins

Congress highlights Article

Highlights from EAN 2022 — Day 1 — June 25th

Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of...
Anxiety 22 Jun, 2022 Read Time: 6 mins

Article

Optimising clinical management in panic disorder

Panic disorder (PD) is characterised by recurrent and predominantly unpredictable panic attacks that...
Anxiety 22 Jun, 2022 Read Time: 5 mins

Article

Optimising clinical management in generalised anxiety disorder

Generalised anxiety disorder (GAD) is characterised by excessive, out of proportion, hard to control,...
Schizophrenia 12 Apr, 2022 Read Time: 2 mins

Congress highlights Article

Are prior mood disorders more important than positive symptoms for predicting psychosis?

Predicting which individuals will develop a psychotic disorder or transition from high risk of...
Alzheimer's Disease 22 Mar, 2022 Read Time: 3 mins

Congress highlights

New perspectives on Alzheimer’s disease

Alzheimer’s disease is not part of normal aging. It is a brain disorder and not all people with...
Alzheimer's Disease 17 Mar, 2022 Read Time: 3 mins

Congress highlights

A simple test combination for identifying early Alzheimer’s disease

Many people experience mild cognitive decline, but what is their risk of developing Alzheimer’s...
Alzheimer's Disease 07 Dec, 2021 Read Time: 2 mins

Congress highlights

Memory Lapses, Mild Cognitive Impairment and Cognitive Enhancers

In this engaging session from the 2021 virtual Neurological Association of South Africa (NASA)...
Depression, Schizophrenia 14 Oct, 2021 Read Time: 5 mins

Satellite symposium

Beyond symptoms: the importance of hearing the patient’s voice in measuring life engagement

Historically, the definition of mental illness has been diagnosis-focused, with successful treatment...
Depression 14 Oct, 2021 Read Time: 4 mins

Satellite symposium

Early life adversities and mental illness: from vulnerability to treatment response

Exposure to stress, particularly early in life, is a risk factor for a number of psychiatric...
Mental Health 06 Oct, 2021 Read Time: 3 mins

Congress highlights

Highlights from ECNP 2021 — Day 4 — October 5th

Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
Mental Health 05 Oct, 2021 Read Time: 3 mins

Congress highlights

Highlights from ECNP 2021 — Day 3 — October 4th

Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
Schizophrenia 04 Oct, 2021 Read Time: 4 mins

Satellite symposium

Small steps for big impact in treatment of schizophrenia

Functional recovery is an important goal in treating schizophrenia, but one that can be hard to...
Mental Health 04 Oct, 2021 Read Time: 4 mins

Congress highlights

Highlights from ECNP 2021 — Day 2 — October 3rd

Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
Mental Health 03 Oct, 2021 Read Time: 3 mins

Congress highlights

Highlights from ECNP 2021 — Day 1 — October 2nd

Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College...
Schizophrenia 20 Jul, 2021 Read Time: 3 mins

Satellite symposium

Long-acting injectable antipsychotics in clinical practice

For patients with schizophrenia, appropriate use of long-acting injectable antipsychotics lowers the...
Depression 20 Jul, 2021 Read Time: 3 mins

Satellite symposium

Promising data in depression associated with emotional blunting or trauma

Treatment for depression should be tailored to individuals’ history and presentation. Patients with...
Migraine, Alzheimer's Disease 23 Jun, 2021 Read Time: 2 mins

Congress highlights

Highlights from EAN 2021 — Day 4

Today, 22 June, Day 4 of the 7th Congress of the European Academy of Neurology – Vienna 2021, was the...
Migraine, Alzheimer's Disease 22 Jun, 2021 Read Time: 2 mins

Congress highlights

Highlights from EAN 2021 — Day 3

Progress in Mind’s coverage of the 7th Congress of the European Academy of Neurology – Vienna 2021...
Alzheimer's Disease 21 Jun, 2021 Read Time: 3 mins

Congress highlights

New more accessible and affordable techniques for identifying people at risk of Alzheimer’s disease

In specialist clinics, cerebrospinal fluid biomarkers for Abeta1-42, Abeta1-40, tTau, and pTau or...
Migraine, Alzheimer's Disease 20 Jun, 2021 Read Time: 2 mins

Congress highlights

Highlights from EAN 2021 — Day 2

The exciting live and connected virtual experience for presenters and attendees of the 7th Congress...
Migraine 20 Jun, 2021 Read Time: 3 mins

Congress highlights

Do preventive anti CGRP treatments have a role in the acute migraine attack?

Antibodies against the sensory neuropeptide calcitonin gene‑related peptide (CGRP) are showing...
Migraine, Alzheimer's Disease 19 Jun, 2021 Read Time: 3 mins

Congress highlights

Highlights from EAN 2021 — Day 1

Welcome to Progress in Mind’s live coverage of EAN 2021. This 7th Congress of the European Academy of...
Migraine 15 Jun, 2021 Read Time: 2 mins

Congress highlights

Preventive therapy reduces interictal burden of migraine

The impact of migraine on a person’s life is multi-faceted; not only is there substantial functional...
Migraine 15 Jun, 2021 Read Time: 2 mins

Congress highlights

Steps towards improving quality of life for patients with migraine

Is it necessary to consider both patients and treating physicians’ views when investigating therapy...
Migraine 15 Jun, 2021 Read Time: 2 mins

Congress highlights

Who should have migraine preventive treatment and how effective are these therapies?

Migraine preventive therapy is used to reduce frequency, duration, or severity of attacks of episodic...
Migraine 20 Apr, 2021 Read Time: 2 mins

Satellite symposium

How does chronic migraine affect everyday life?

The disabling headaches and symptoms of chronic migraine can impact almost every aspect of life. What...
Schizophrenia 12 Apr, 2021 Read Time: 3 mins

Satellite symposium

Long-acting injectables together with medical team training may facilitate functional recovery

Early use of long-acting injectables together with targeted staff training may facilitate short- and...
Schizophrenia 08 Mar, 2021 Read Time: 2 mins

Satellite symposium

Early onset schizophrenia needs patient-specific management

Early diagnosis and effective, well-tolerated treatment of early-onset schizophrenia are crucial to...
Depression, Schizophrenia 19 Feb, 2021 Read Time: 4 mins

Congress highlights

Why do we need new treatments for major depressive disorder and schizophrenia?

Atypical antipsychotics are the mainstay of treatment for schizophrenia and a therapeutic option as...
Schizophrenia 15 Feb, 2021 Read Time: 3 mins

Interview

Treatment goals in schizophrenia

Dr Miquel Bioque, Hospital Clinic, Barcelona, talks to our correspondent about the need to change...
Schizophrenia 02 Feb, 2021 Read Time: 3 mins

Satellite symposium

Why use of long acting injectables is an urgent issue

Long acting injectable antipsychotics are often withheld until later stages of schizophrenia, but...
Schizophrenia 02 Feb, 2021 Read Time: 2 mins

Satellite symposium

The importance of patient functioning in schizophrenia

Speakers at this satellite symposium discussed the importance of addressing not just the symptoms of...
Schizophrenia 18 Jan, 2021

Podcast

Do long-acting injectable antipsychotics have a role in early-phase schizophrenia?

Early intervention and continuous treatment in schizophrenia are key to ensuring good outcomes. This...
Mental Health 08 Jan, 2021

Podcast

Digital technologies - an opportunity to achieve Mental Health for All

Digital technologies have the potential to transform the theme for World Mental Health Day 2020 —...
Depression 18 Dec, 2020 Read Time: 3 mins

Article

Depression in men: less frequent, or just less recognized?

International Men’s Day, among other aims, seeks to increase awareness of health challenges that...
Alzheimer's Disease 09 Dec, 2020 Read Time: 2 mins

Congress highlights

Measuring tau accumulation and progression

The ability of PET to map regional changes in tau pathology over time provides important insights...
Schizophrenia 19 Oct, 2020 Read Time: 3 mins

Satellite symposium

Engaging patients with schizophrenia in decision-making to improve outcomes

Medication adherence is a challenge for many patients, especially with chronic diseases, such as...
Mental Health 03 Oct, 2020 Read Time: 2 mins

Congress highlights

Brain health becomes a global priority

For years, the massive burden of mortality and morbidity caused by neurological diseases was not...
Schizophrenia 13 Sep, 2020 Read Time: 3 mins

Satellite symposium

Do long-acting injectable antipsychotics have a role in early-phase schizophrenia?

Early intervention and continuous treatment in schizophrenia are key to ensuring good outcomes. This...
Alzheimer's Disease 12 Sep, 2020 Read Time: 2 mins

Congress highlights

TDP-43: a newly-recognized route to cognitive decline

There is growing clinical interest in TDP-43 proteinopathy, a relatively recent and fast-moving area...
Depression 11 Sep, 2020 Read Time: 3 mins

Satellite symposium

Aiming for the top of the “recovery tree”

It is a powerful image: full functional recovery from depression and enhanced quality of life are the...
Mental Health 05 Sep, 2020 Read Time: 2 mins

Article

Digital technologies — an opportunity to achieve Mental Health for All

Digital technologies have the potential to transform the theme for World Mental Health Day 2020 —...
Migraine 21 Jul, 2020 Read Time: 2 mins

Congress highlights

CGRP – new perspectives in headache management

Three new takes on the potential for calcitonin gene-related proteins were presented at this year’s...
Depression, Bipolar 10 Jul, 2020 Read Time: 2 mins

Congress highlights

How should treatment be tailored for the DSM-5 mixed features specifier?

The mixed features specifier for manic and depressive episodes introduced in DSM-5 reflects the...
Alzheimer's Disease 30 Jun, 2020 Read Time: 2 mins

Congress highlights

Study motivated by apathy

Conversion from mild cognitive impairment to Alzheimer’s disease dementia is not related to the...
Migraine 29 Jun, 2020 Read Time: 2 mins

Article

COVID-19 - crisis and migraine management?

The current COVID-19 pandemic provides short‑term challenges for migraine management, but can these...
Depression, Bipolar 24 Jun, 2020 Read Time: 2 mins

Congress highlights

What are the roles of abnormal metabolism and inflammation in mood disorders?

Inflammation and abnormal metabolism are observed in major depressive and bipolar disorders, said...
Alzheimer's Disease 19 Jun, 2020 Read Time: 3 mins

Congress highlights

Imaging advances diagnosis and staging in dementias

Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and...
Schizophrenia 12 May, 2020 Read Time: 3 mins

Article

Negative symptoms in schizophrenia – get thee gone!

Negative symptoms in schizophrenia – faculties apparently lacking or somehow diminished – have long...
Mental Health 17 Apr, 2020

COVID-19: An interview with Prof Roger McIntyre on the repercussions on mental health
19 Mar, 2020 Read Time: 3 mins

Congress highlights

Digital approach to brain disorders needs ethical perspective

With the rapidly expanding frontiers of digital health, as with any move into the/this new territory,...
Depression, Schizophrenia 12 Mar, 2020 Read Time: 1 min

Congress highlights

Measurement-based care: How can we improve outcomes for patients with depression and schizophrenia

Measurement-based care (MBC) can improve outcomes and reduce health disparities for serious mental...
Depression 02 Mar, 2020 Read Time: 3 mins

Article

Is sexual dysfunction a symptom of depression, or a symptom of the treatment of depression?

At a Lundbeck General Practitioner Day held in Pretoria, Dr Jireh Serfontein, a sexual health...
Schizophrenia 26 Feb, 2020 Read Time: 3 mins

Article

The neurobiology of conversion to psychosis – emerging findings from the SHARP study

The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to...
Schizophrenia 14 Feb, 2020 Read Time: 3 mins

Congress highlights

Core components of the Coordinated Specialty Care model for first-episode psychosis

The Coordinated Specialty Care (CSC) model for first-episode psychosis (FEP) is an evidence-based...
Mental Health 23 Jan, 2020 Read Time: 4 mins

Congress highlights

How are genes involved in tailoring psychiatric treatment?

Psychiatrists need an understanding of genome-wide association studies (GWAS), pharmacogenomics, and...
Alzheimer's Disease 23 Jan, 2020 Read Time: 3 mins

Congress highlights

Assessing and managing agitation associated with Alzheimer’s dementia

Agitation is common among patients with Alzheimer’s disease (AD) and results in a range of behavioral...
Mental Health 30 Oct, 2019 Read Time: 3 mins

Congress highlights

The new technologies transforming psychiatric practice and patient outcomes

Data-driven approaches to psychiatric diagnosis and practice fueled by the abundance of information...
Schizophrenia 08 Oct, 2019 Read Time: 5 mins

Satellite symposium

Are relapse prevention and functioning sufficiently prioritized in the treatment of schizophrenia?

Improving adherence and reducing rates of relapse and rehospitalization are of paramount importance...
Depression 04 Oct, 2019 Read Time: 4 mins

Satellite symposium

Emotional blunting: unresolved MDD symptom or effect of treatment?

Some evidence suggests that emotional blunting is a side effect of therapy, but other evidence...
Depression 04 Oct, 2019 Read Time: 4 mins

Satellite symposium

Patient goals and measuring outcome crucial in MDD

Asking people what they most want from depression treatment, treating to target, measurement-based...
Schizophrenia 20 Sep, 2019 Read Time: 4 mins

Congress highlights

Can we be bothered about apathy? Approaching negative symptoms in schizophrenia

There has been an increased interest in research for the negative symptoms of schizophrenia over the...
Depression 20 Sep, 2019 Read Time: 4 mins

Satellite symposium

Targeting what matters most for patients with depression: Strategies for promoting full functional recovery

Major depression is a common and serious condition with symptoms across domains and being very...
Alzheimer's Disease 06 Sep, 2019 Read Time: 3 mins

Congress highlights

Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease?

The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of...
Alzheimer's Disease 06 Sep, 2019 Read Time: 3 mins

Congress highlights

The emerging relationship between plasma and brain amyloid-β — does it play a role in the pathogenesis in Alzheimer’s disease?

Reliable plasma amyloid-β (Aβ) measurement is now possible using new highly sensitive techniques, and...
Mental Health 20 Aug, 2019 Read Time: 3 mins

Congress highlights

Beyond the guidelines: Precision Medicine

Despite the attractiveness of precision medicine (PM) for providing personalized patient management,...
Depression 01 Aug, 2019 Read Time: 5 mins

Congress highlights

Clinical Use of Body-Swapping! Don’t worry, it’s Virtual Reality!

Digital technologies are unfamiliar to many physicians, yet there is a huge demand for their...
Alzheimer's Disease 22 Jul, 2019 Read Time: 3 mins

Congress highlights

Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease?

The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of...
Parkinson's Disease 17 Apr, 2019 Read Time: 4 mins

Congress highlights

Gait freezing - defrosted

The assessment and therapeutic options for complex gait disorders has never been so promising. During...
Mental Health 10 Apr, 2019 Read Time: 4 mins

Congress highlights

Psychiatrist and patient partnership encourages trust and effective care

We have so many shared objectives – notably ensuring adequate resources are given to mental health –...
Depression, Bipolar 20 Feb, 2019 Read Time: 3 mins

Article

Predicting vulnerability to mood disorders and treatment response

Major depressive disorder (MDD) is ultimately about how the brain responds to the environment, but...
Bipolar, Schizophrenia 11 Feb, 2019 Read Time: 3 mins

Congress highlights

Reconceptualizing psychosis based on biomarker analysis – personalized therapy to prevent disease progression

When an extensive biomarker study characterizing diverse aspects of brain function unexpectedly...
Schizophrenia 06 Feb, 2019 Read Time: 4 mins

Congress highlights

Tackling the elephant in the room: non-adherence in schizophrenia

The challenges and consequences of non-adherence to treatment in schizophrenia, and some novel ways...
Mental Health 04 Feb, 2019 Read Time: 3 mins

Article

Train, test, predict: Using big data and machine learning in psychiatry

Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine clinical...
Schizophrenia 31 Jan, 2019 Read Time: 4 mins

Article

Changing the course of schizophrenia: biology, psychology and livelihood

How to manage and mitigate some long-term problems associated with schizophrenia, and improve...
Schizophrenia 22 Jan, 2019 Read Time: 4 mins

Article

Future of schizophrenia treatment: Where do we go now?

Over the next decade, the outcomes for patients with schizophrenia should improve considerably,...
Alzheimer's Disease 22 Jan, 2019 Read Time: 5 mins

Article

Could targeting the brain’s clearance systems be beneficial in Alzheimer’s Disease?

Amyloid-beta (Aβ) accumulation in Alzheimer’s Disease (AD) may, in part, be due to an impairment in...
Depression 18 Jan, 2019

Podcast

Digital technology and the patient experience - what are the opportunities and challenges of ‘mHealth’?

Read the full feature here.
Depression 15 Jan, 2019 Read Time: 4 mins

Article

Collaborative care for comorbid depression: cost-effectiveness and implementation

Collaborative care (CC) is a care model for patients with comorbid depression and chronic disease in...
Alzheimer's Disease 27 Oct, 2018 Read Time: 4 mins

Congress highlights

It’s in the blood – identification of plasma biomarkers brings hope for screening and early detection of Alzheimer’s disease

The recent discovery and validation of blood biomarkers offers huge potential for the early...
Alzheimer's Disease 22 Oct, 2018 Read Time: 4 mins

Article

New insights into Apolipoprotein E and Alzheimer’s Disease

Apolipoprotein E4 is a major risk factor for Alzheimer’s Disease and is strongly related to the...
Depression 07 Oct, 2018 Read Time: 2 mins

Congress highlights

Functional recovery in depression: are we doing the right thing for the treatment of depression?

Major depressive disorder (MDD) is a heterogeneous disease characterized by many different mood,...
Depression, Schizophrenia 19 Jun, 2018 Read Time: 4 mins

Congress highlights

Why do we need new treatments for major depressive disorder and schizophrenia?

Atypical antipsychotics are the mainstay of treatment for schizophrenia and a therapeutic option as...
Mental Health 15 May, 2018 Read Time: 4 mins

Congress highlights

The promise of big data analysis – precision psychiatry and therapeutic targeting

Psychiatric diagnosis - according to DSM-5 - is largely based on psychiatric symptoms, with a great...
Mental Health 14 May, 2018 Read Time: 4 mins

Congress highlights

The promise of big data analysis – precision psychiatry and therapeutic targeting

Psychiatric diagnosis - according to DSM-5 - is largely based on psychiatric symptoms, with a great...
Parkinson's Disease 09 May, 2018 Read Time: 4 mins

Congress highlights

Advances in Parkinson’s disease research: one step closer to identify subjects in the prodromal stage, predicting conversion and potential for disease-modifying therapy

The incidence of Parkinson’s disease (PD) is increasing. The reasons are unknown. Identifying people...
Bipolar 09 May, 2018 Read Time: 3 mins

Congress highlights

A new era for the identification and treatment of bipolar disorder

We are in a new era for the identification and treatment of bipolar disorder, said Eduard Vieta,...
Depression, Schizophrenia 09 May, 2018 Read Time: 4 mins

Congress highlights

E-mental health is revolutionizing and reshaping mental health practice worldwide

E-mental health is revolutionizing and reshaping mental health care practice worldwide. This...
Schizophrenia 08 May, 2018 Read Time: 3 mins

Article

Effective treatment of schizophrenia requires a patient-centered approach

Recognition of how people with schizophrenia interact and cope with their experiences is necessary...
Schizophrenia 08 May, 2018 Read Time: 3 mins

Article

Early intervention in schizophrenia may improve long-term outcome

Schizophrenia may not be as disabling if identified and treated early, resulting in many benefits for...
Schizophrenia 08 May, 2018 Read Time: 5 mins

Congress highlights

Recovery – from schizophrenia symptoms to well-being

Recovery in an important focus in the treatment and management of schizophrenia but what exactly is...
Depression 08 May, 2018 Read Time: 4 mins

Congress highlights

Effective treatment of depression enables a return to a pre-depression lifestyle

Treating major depressive disorder (MDD) effectively to enable patients to return to their...
Schizophrenia 08 May, 2018 Read Time: 4 mins

Congress highlights

If one antipsychotic is good, why aren’t two better? Polypharmacy debated

Increased risk of side effects, reduced compliance, lack of rationale and, above all, no evidence of...
Schizophrenia 19 Apr, 2018 Read Time: 3 mins

Article

Effective treatment of schizophrenia requires a patient-centered approach

Recognition of how people with schizophrenia interact and cope with their experiences is necessary...
Schizophrenia 30 Mar, 2018 Read Time: 3 mins

Article

Early intervention in schizophrenia may improve long-term outcome

Schizophrenia may not be as disabling if identified and treated early, resulting in many benefits for...
Parkinson's Disease 23 Mar, 2018 Read Time: 4 mins

Congress highlights

Advances in Parkinson’s disease research: one step closer to identify subjects in the prodromal stage, predicting conversion and potential for disease-modifying therapy

The incidence of Parkinson’s disease (PD) is increasing. The reasons are unknown. Identifying people...
Alzheimer's Disease 22 Mar, 2018 Read Time: 4 mins

Congress highlights

Could astrocyte activation initiate AD pathology 20 years before diagnosis?

Neuroimaging techniques demonstrate a 20-year pathophysiological pathway preceding the development of...
Alzheimer's Disease 19 Mar, 2018 Read Time: 3 mins

Congress highlights

Essential elements for Alzheimer’s disease clinical trials

Stronger links between novel agents and their targets, more precise selection of patients, and better...
Schizophrenia 07 Mar, 2018 Read Time: 5 mins

Congress highlights

Recovery – from schizophrenia symptoms to well-being

Recovery in an important focus in the treatment and management of schizophrenia but what exactly is...
Bipolar 07 Mar, 2018 Read Time: 3 mins

Congress highlights

A new era for the identification and treatment of bipolar disorder

We are in a new era for the identification and treatment of bipolar disorder, said Eduard Vieta,...
Depression 06 Mar, 2018 Read Time: 4 mins

Congress highlights

Effective treatment of depression enables a return to a pre-depression lifestyle

Treating major depressive disorder (MDD) effectively to enable patients to return to their...
Schizophrenia 06 Mar, 2018 Read Time: 4 mins

Congress highlights

If one antipsychotic is good, why aren’t two better? Polypharmacy debated

Increased risk of side effects, reduced compliance, lack of rationale and, above all, no evidence of...
Depression, Schizophrenia 06 Mar, 2018 Read Time: 4 mins

Congress highlights

E-mental health is revolutionizing and reshaping mental health practice worldwide

E-mental health is revolutionizing and reshaping mental health care practice worldwide. This...
Mental Health 20 Sep, 2017 Read Time: 2 mins

Article

Value of Treatment: European Brain Council publishes landmark report

Greater clinical benefit for patients and gains in cost-effectiveness for society -- both can be...
Schizophrenia 04 Sep, 2017 Read Time: 3 mins

Satellite symposium

Priorities and preferences of people with schizophrenia: need for new focus

Priorities are what people value, and preferences show how they make trade-offs between one outcome...
Schizophrenia 04 Sep, 2017 Read Time: 3 mins

Congress highlights

Keeping a healthy brain

Preventing the long-term consequences of schizophrenia, and particularly of multiple relapses, is the...
Depression 04 Sep, 2017 Read Time: 5 mins

Body dysmorphic disorder

When we fall down, can we get back up again?

Major depressive episodes often leave patients functionally incapacitated even after depressive...
Depression 04 Sep, 2017 Read Time: 2 mins

Interview

Treatment goals and challenges in depression - a New Zealand doctor’s perspective

Dr Teresa Fontillas-Luis works in an acute psychiatric unit in New Zealand. At ENCP 2017, Dr...
Schizophrenia 04 Sep, 2017 Read Time: 6 mins

Satellite symposium

Preventing schizophrenia relapse key to optimizing outcome

Sustained remission and good functional outcome depend on the interaction between factors we cannot...
Schizophrenia 04 Sep, 2017 Read Time: 4 mins

Congress highlights

Positive action on negative symptoms

Negative symptoms are experienced by more than 50% of patients with schizophrenia. They are often a...
Schizophrenia 30 May, 2017 Read Time: 3 mins

Congress highlights

Coming soon….Updated APA guideline on schizophrenia

Practice guidelines assimilate the evidence-base and so help support daily clinical decision-making....
Schizophrenia 30 Apr, 2017 Read Time: 4 mins

Satellite symposium

Prevention, early intervention, adherence and function: links in optimising outcome

Help patients function, and then they will get better, is an alternative to the traditional approach...
Depression, Schizophrenia 10 Apr, 2017 Read Time: 4 mins

Congress highlights

The tip of the iceberg

At the EPA 2017 symposium on autism spectrum disorders, the latest approaches being employed to dive...
Schizophrenia 02 Apr, 2017 Read Time: 4 mins

Congress highlights

Can anti-psychotics be discontinued in remission?

Despite some shift of opinion in response to the arguments presented, the outcome was that two-thirds...
Depression 29 Mar, 2017 Read Time: 1 min

Download

THINC-it® physician guide

The THINC-it® user guide is now available and can be downloaded here. It includes a general operation...
Depression 09 Feb, 2017 Read Time: 2 mins

Feature

Molecular mechanisms underpin gene/environment interaction

Polygenic risk factors interact with the environment to increase vulnerability to depression. Do...
Depression 06 Oct, 2016 Read Time: 3 mins

Interview

“To define remission, look to the words of the patient.” An interview with Dr Nabil Mikati, Beirut, Lebanon
Depression 06 Oct, 2016 Read Time: 2 mins

Interview

“To define remission, look to the words of the patient.” An interview with Dr Nabil Mikati, Beirut, Lebanon
Depression 18 Oct, 2014 Read Time: 2 mins

Interview

Challenges treating mood disorders

An interview with Dr Aideen Moran & Dr Doreen O’Rourke

Progress in Mind Middle East and Africa HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Middle East and Africa click here.

Register Already registered

Brought to you by

© 2022 Lundbeck Middle East and Africa

PROGRESS IN MIND MIDDLE EAST & AFRICA

Privacy Information and Disclaimer

subscribe newsletter

Sign up for newsletter

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue